Neuland Laboratories Ltd 524558
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹21,392.65
- Day Range
- ₹20,730.30–21,649.10
- 52-Week Range
- ₹11,500.00–24,235.05
- Bid/Ask
- ₹0.00 / ₹0.00
- Shares Outstanding
- 12.83M
- Market Cap
- ₹275.80B
- Volume/Avg
- 4,152 / 4,369
Key Statistics
- Price/Earnings (Normalized)
- 55.09
- Price/Sales
- 11.63
- Dividend Yield (Trailing)
- 0.16%
- Dividend Yield (Forward)
- 0.16%
- Dividend Payment Schedule
- Aug
- Total Yield
- 0.16%
Company Profile
Neuland Laboratories Ltd is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The group has only one reportable segment manufacture of active pharmaceutical ingredients and allied services. It has presence in India, Europe, USA and North America, and Rest of the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 3,881
- Website
- https://www.neulandlabs.com
Valuation
|
Metric
|
524558
|
|---|---|
Price/Earnings (Normalized) | 55.09 |
Price/Book Value | 14.71 |
Price/Sales | 11.63 |
Price/Cash Flow | 59.42 |
Price/Earnings
524558
Financial Strength
|
Metric
|
524558
|
|---|---|
Quick Ratio | 1.24 |
Current Ratio | 2.09 |
Interest Coverage | 26.41 |
Quick Ratio
524558
Profitability
|
Metric
|
524558
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
524558
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|>tZ#!h& | LOCK|gvNDD | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|w?>kF&R | LOCK|p%P$z | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|?b>$q@? | LOCK|@pg | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|b<JKNf>j | LOCK|c@y | $29B | |||
| Viatris Inc
VTRS
| LOCK|YJ%D%P | LOCK|d&T | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|hL | LOCK|@B | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Y&Hh^p | LOCK|&& | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|SY%m>>@ | LOCK|?< | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|f>&vYs | LOCK|ml!xl | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|?%&z%tz | LOCK|Wvv | $2B |
United States